Observational studyThe Journal of international medical research2020

Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma.

Fang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.